Botanix Pharmaceuticals Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported sales was AUD 0.37793 million compared to AUD 0.043649 million a year ago. Net loss was AUD 5.47 million compared to AUD 4.6 million a year ago.

Basic loss per share from continuing operations was AUD 0.0038 compared to AUD 0.0045 a year ago. Diluted loss per share from continuing operations was AUD 0.0038 compared to AUD 0.0045 a year ago.